8:00–8:15 a.m.	Updates from the Pediatric Nuclear Medicine Dose Reduction Working Group
	S. Ted Treves, MD
8:15–8:35 a.m.	Multimodality Imaging of Neuroblastoma
	Susan E. Sharp, MD
8:35–8:45 a.m.	Curie Scoring - Prognostic Implications: How to do It
	Marguerite T. Parisi, MD, MS Ed
8:45–9:30 a.m.	Advances in Neuroblastoma Therapy: The role of I-131 MIBG
	Meaghan P. Granger, MD
9:30–9:45 a.m.	Break
9:45–10:15 a.m.	Developing an Institutional I-131 MIBG Therapy Program: Key Issues
	Frederic Fahey, PhD
10:15–10:25 a.m.	Reducing Dose to Nuclear Medicine Personnel During I-131 MIBG Therapy
	Michael J. Gelfand, MD
10:25–10:45 a.m.	Radiolabeled Somatostatin Analogues for Treatment of Neuroendocrine Tumors
	Yusuf Menda, MD
10:45–10:55 a.m.	Imaging in Pediatric Thyroid diseases
	Deepa R. Biyyam, MBBS
10:55–11:05 a.m.	Fine Needle Biopsy in Children with Thyroid Nodules
	Ganesh Krishnamurthy, MD
11:05–11:35 a.m.	I-131 Radiotherapy of Pediatric Thyroid Cancer
	Steven G. Waguespack, MD
11:35–11:50 a.m.	Radioimmunotherapy of Lymphoma
	Hedieh Eslamy, MD
11:50 a.m.–12:00 p.m.	Question and Answer
	Adjourn